Eli Lyons, Ph.D. candidate, is the CEO of Tupac Bio. Eli completed a master’s degree in Computer Engineering and Embedded Systems in America prior to commencing his doctoral studies at the University of Tokyo.
His Ph.D. work has involved a mix of hands on wet-lab work and bioinformatics analyses of high-throughput mutagenic screens. He co-founded Tupac Bio to develop intuitive software solutions to emerging problems in biodesign and high-throughput screening.
Tupac Bio is combining software with third generation sequencing and data analysis to transform the biologic drug discovery process. Their cloud software, Tupac Bio Designer, allows researchers in drug development to customize drug candidates through software designed synthetic DNA. Their intuitive DNA design software empowers researchers to use a more efficient drug screening process that integrates high-throughput sequencing technology and data analysis.